Zydus Lifesciences’ shares fell 6% to Rs 1,109 after acquiring a 50% stake in Sterling Biotech for Rs 550 crore. Analysts maintain neutral ratings with target prices of Rs 1,020 and Rs 1,210.
Wakefit IPO: Check GMP, price band, review, subscription and other details
Wakefit Innovations, known for its mattresses, is launching its IPO with a positive grey market outlook. The company is raising over Rs 1,200 crore. Despite